Facebook
Instagram
Linkedin
Pinterest
Reddit
Twitter
Youtube
Sign in
Home
Safe Snack Guide
Peanut and Tree Nut Free Edition
Milk (Dairy) Free Edition
Sesame Free Edition
Gluten Free Edition
Custom Edition
Allergence
Coupons & Offers
Resources
Newsletter
SnackSafely Manufacturer Partnership
Take 2 Epinephrine Reminder Flyers
Put Your School on the Map
About Us
SnackSafely Media Kit
SnackSafely Advertising Guide
Terms and Conditions
Privacy Policy
Contact Us
Sign in
Welcome!
Log into your account
your username
your password
Forgot your password?
Terms and Conditions
Password recovery
Recover your password
your email
Search
Home
Safe Snack Guide
Peanut and Tree Nut Free Edition
Milk (Dairy) Free Edition
Sesame Free Edition
Gluten Free Edition
Custom Edition
Allergence
Coupons & Offers
Resources
Newsletter
SnackSafely Manufacturer Partnership
Take 2 Epinephrine Reminder Flyers
Put Your School on the Map
About Us
SnackSafely Media Kit
SnackSafely Advertising Guide
Terms and Conditions
Privacy Policy
Contact Us
Search
Home
Emerging Therapy
Page 22
Emerging Therapy
Latest
Latest
Featured posts
Most popular
7 days popular
By review score
Random
Phase II Trial Now Recruiting, Investigates Microbiome as Immunotherapy Enhancer
Dave Bloom
-
2025/11/21
Anaphylm™ Sublingual Epinephrine Shows Promising Results for Pediatric Anaphylaxis Treatment
Peanut Patch Treatment Continues to Help Toddlers Safely Build Tolerance Over Three Years
Peanut Sublingual Immunotherapy Shows Long-Term Benefits for Young Children
RAPT Therapeutics Launches Phase 2b Trial for Anti-IgE Therapy for Food Allergies
Must See: 'ViewFinder: Food for Thought – Food Allergies'
Dave Bloom
-
2019/04/01
0
European Phase 3 Trial of AR101 Peanut OIT Candidate Meets Primary...
News Wire ~ 3rd Party Press Release
-
2019/03/25
0
US FDA Accepts BLA Filing of Aimmune Therapeutics’ AR101 for Peanut...
News Wire ~ 3rd Party Press Release
-
2019/03/18
0
Update on Delivery of Emergency Epinephrine via Sublingual Film
Dave Bloom
-
2019/03/14
0
FDA Approves Dupixent® (dupilumab) for Moderate-to-severe Atopic Dermatitis in Adolescents
News Wire ~ 3rd Party Press Release
-
2019/03/12
0
Aimmune Therapeutics Presents New AR101 Data Including Demonstrated Reduction in Accidental...
News Wire ~ 3rd Party Press Release
-
2019/02/25
0
FDA Fast Tracks ARS-1 Intranasal Epinephrine Spray
News Wire ~ 3rd Party Press Release
-
2019/02/19
0
Study: Treatment with Omalizumab Raises Tolerance in Patients with Severe Food...
Dave Bloom
-
2019/02/15
0
DBV to Resubmit Application to FDA for Viaskin Peanut Approval in...
News Wire ~ 3rd Party Press Release
-
2019/02/14
0
Government Shutdown Delays Review of AR101 Peanut Oral Immunotherapy Candidate
Dave Bloom
-
2019/01/16
0
1
...
21
22
23
...
30
Page 22 of 30